| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.083 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |